DK1135514T3 - E1b-deleteret adenovirale shuttle-vektorer - Google Patents

E1b-deleteret adenovirale shuttle-vektorer

Info

Publication number
DK1135514T3
DK1135514T3 DK00907050T DK00907050T DK1135514T3 DK 1135514 T3 DK1135514 T3 DK 1135514T3 DK 00907050 T DK00907050 T DK 00907050T DK 00907050 T DK00907050 T DK 00907050T DK 1135514 T3 DK1135514 T3 DK 1135514T3
Authority
DK
Denmark
Prior art keywords
shuttle vectors
gene
deleted adenoviral
adenoviral shuttle
treatment
Prior art date
Application number
DK00907050T
Other languages
English (en)
Inventor
Terry Hermiston
Julie Nye
Original Assignee
Onyx Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onyx Pharma Inc filed Critical Onyx Pharma Inc
Application granted granted Critical
Publication of DK1135514T3 publication Critical patent/DK1135514T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Image Generation (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Image Processing (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00907050T 1999-01-28 2000-01-26 E1b-deleteret adenovirale shuttle-vektorer DK1135514T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11781499P 1999-01-28 1999-01-28
PCT/US2000/002029 WO2000044922A1 (en) 1999-01-28 2000-01-26 E1b-deleted adenoviral shuttle vectors

Publications (1)

Publication Number Publication Date
DK1135514T3 true DK1135514T3 (da) 2009-09-07

Family

ID=22374975

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00907050T DK1135514T3 (da) 1999-01-28 2000-01-26 E1b-deleteret adenovirale shuttle-vektorer

Country Status (10)

Country Link
EP (1) EP1135514B1 (da)
AT (1) ATE431421T1 (da)
AU (1) AU772544B2 (da)
CA (1) CA2360355A1 (da)
CY (1) CY1109288T1 (da)
DE (1) DE60042196D1 (da)
DK (1) DK1135514T3 (da)
ES (1) ES2325303T3 (da)
PT (1) PT1135514E (da)
WO (1) WO2000044922A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030086903A1 (en) 2001-11-02 2003-05-08 Genvec, Inc. Therapeutic regimen for treating cancer
AU2003206815A2 (en) * 2002-02-01 2003-09-02 Transgene S.A. Adenoviral vectors for modulating the cellular activities associated with PODs
US9073980B2 (en) 2009-03-02 2015-07-07 The Regents Of The University Of California Tumor selective E1a and E1b mutants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670488A (en) * 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
US5801029A (en) * 1993-02-16 1998-09-01 Onyx Pharmaceuticals, Inc. Cytopathic viruses for therapy and prophylaxis of neoplasia
US5981275A (en) * 1997-04-14 1999-11-09 Genzyme Corporation Transgene expression system for increased persistence

Also Published As

Publication number Publication date
ATE431421T1 (de) 2009-05-15
AU2861300A (en) 2000-08-18
AU772544B2 (en) 2004-04-29
DE60042196D1 (de) 2009-06-25
PT1135514E (pt) 2009-07-20
CA2360355A1 (en) 2000-08-03
WO2000044922A1 (en) 2000-08-03
EP1135514B1 (en) 2009-05-13
ES2325303T3 (es) 2009-09-01
EP1135514A1 (en) 2001-09-26
CY1109288T1 (el) 2014-07-02

Similar Documents

Publication Publication Date Title
DK0797676T3 (da) Rekombinant adenoviral vektor og fremgangsmåder til anvendelse deraf
NO950939D0 (no) Defektive adenovirusvektorer og deres anvendelse i gene-terapien
DK1312678T3 (da) Rekombinant MVA-virus og anvendelse deraf
EP0710288A4 (en) ADENOVIRAL VECTORS FOR TREATMENT OF HEMOPHILIA
ATE320271T1 (de) Neuartige adenovirale vektoren, verpackungsszellinien, rekombinante adenoviren und verfahren
IS4762A (is) Samfallandi eitlaveiru genaferjukerfi og frumulínur
NZ508399A (en) Packaging cell lines for use in facilitating the development of high capacity adenoviral vectors
ATE295853T1 (de) Langes pentraxin ptx3 enthaltende pharmazeutische zusammensetzungen
CY1109288T1 (el) Αδενοϊικοι φορεις οχηματα με απαλοιφη ε1β
DE60237013D1 (de) Replizierende adenovirus-vektoren
DK1071805T3 (da) Adenovirusvektorer til sygdomsbehandling
DK0781344T3 (da) Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme
FR2799472B1 (fr) Preparation d'adenovirus recombinants et de banques adenovirales
WO2000029573A3 (en) Adenoviral vectors
WO2000022136A3 (en) Recombinant e1a deleted adenoviral vectors
UA70909C2 (uk) Рекомбінантний аденовірусний вектор, фармацевтична композиція, що його містить, та набір для зменшення проліферації пухлинних клітин
BR0009666A (pt) Adenovìrus recombinante e mutante derivado de adenovìrus bovino tipo 1
WO2003031633A3 (de) Adenovirales vektorsystem
ADENOVIRUS REPLICATION COMPETENT ADENOVIRUS
MY157873A (en) Recombinant mva virus, and the use thereof